Home › Companies › LIFECORE BIOMEDICAL INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and LIFECORE BIOMEDICAL INC.’s Form 8-K, filed November 8, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of November 7, 2024: 6 items on LIFECORE BIOMEDICAL INC.’s Form 8-K, filed November 8, 2024: 2 approved · 4 passed (calculated).
Meeting of August 15, 2024: 8 items on LIFECORE BIOMEDICAL INC.’s Form 8-K, filed August 21, 2024: 4 approved · 4 passed (calculated).
Meeting of April 10, 2025: 2 items on LIFECORE BIOMEDICAL INC.’s Form 8-K, filed April 10, 2025: 2 approved.
Notable dissent: 1 director (11.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2024-2025 2025-2026
Activist investors: Legion Partners (13D, 17.3%, as of September 28, 2026) · Wynnefield Capital (13D, 14.3%, as of September 29, 2026) · 22NW (13D, 6.7%, as of July 2, 2026)
Next meeting: Special Meeting, December 23, 2026: what’s on the ballot
Explore LIFECORE BIOMEDICAL INC. in the interactive database Compare manager voting policies
These tallies are LIFECORE BIOMEDICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed November 8, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. LIFECORE BIOMEDICAL INC. reported 3 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Matthew Korenberg | 23,645,673 | 191,321 | -- | 12,392 | 7,498,295 | 99.2% | Passed (calculated) | — |
| Elect Director: Humberto Antunes | 23,712,493 | 124,501 | -- | 12,392 | 7,498,295 | 99.5% | Passed (calculated) | — |
| Elect Director: Nelson Obus | 21,721,070 | 2,115,224 | -- | 13,092 | 7,498,295 | 91% | Passed (calculated) | — |
| Elect Director: Katrina Houde | 20,973,514 | 2,827,981 | -- | 47,891 | 7,498,295 | 88% | Passed (calculated) | — |
| 2. The appointment of BDO USA, P.C | 31,279,291 | 29,609 | 38,781 | -- | -- | 99.9% | Approved | — |
| 3. The compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes | 23,645,284 | 163,003 | 41,099 | -- | 7,498,295 | 99.3% | Approved | — |
Source: LIFECORE BIOMEDICAL INC., Form 8-K, filed with the SEC on November 8, 2024 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Raymond Diradoorian | 21,156,969 | 534,131 | -- | 3,411 | 7,668,901 | 98% | Passed (calculated) | — |
| Elect Director: Paul Josephs | 21,583,747 | 82,517 | -- | 28,247 | 7,668,901 | 99.6% | Passed (calculated) | — |
| Elect Director: Joshua E. Schechter | 20,771,379 | 919,721 | -- | 3,411 | 7,668,901 | 96% | Passed (calculated) | — |
| 3. The appointment of BDO USA, P.C | 29,200,561 | 143,197 | 19,654 | -- | -- | 99.5% | Approved | — |
| 4. The compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes | 21,573,480 | 112,769 | 8,262 | -- | 7,668,901 | 99.5% | Approved | — |
| 5. The amendment to the Company's 2019 Stock Incentive Plan, with votes | 20,795,332 | 895,344 | 3,835 | -- | 7,668,901 | 96% | Approved | — |
| 7. Amendment to the Certificate of Incorporation to increase the number of authorized shares of Common Stock | 26,647,770 | 2,676,222 | 39,420 | -- | -- | 91% | Approved | — |
| Holders of Common Stock | 21,939,394 | 2,676,222 | 39,420 | -- | -- | 89% | Passed (calculated) | — |
Source: LIFECORE BIOMEDICAL INC., Form 8-K, filed with the SEC on August 21, 2024 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. The Issuance Proposal, with votes | 24,098,218 | 444,639 | 33,281 | -- | -- | 98% | Approved | — |
| 2. The Adjournment Proposal, with votes | 28,882,501 | 464,086 | 35,505 | -- | -- | 98% | Approved | — |
Source: LIFECORE BIOMEDICAL INC., Form 8-K, filed with the SEC on April 10, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
105 asset managers disclosed a vote on at least one LIFECORE BIOMEDICAL INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LIFECORE BIOMEDICAL INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held November 7, 2024.
Combines 4 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: To elect four non-Series A Preferred Director, as described in the Proxy Statement, for a term expiring at the 2025 annual meeting stockholders and until their successors are duly elected and qualified: Humberto Antunes
LIFECORE BIOMEDICAL INC.’s own tally for this item (“Elect Director: Humberto Antunes”): 23,712,493 for, 124,501 against, per its Form 8-K filed November 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 2,029,069 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,293,361 | 0 | 0 | 0 | For |
| BlackRock | 229,840 | 0 | 0 | 0 | For |
| Fidelity | 146,786 | 0 | 0 | 0 | For |
| Charles Schwab | 60,505 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 55,700 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 42,480 | 0 | 0 | 0 | For |
| Equitable | 27,170 | 0 | 0 | 0 | For |
| TIAA | 26,237 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,000 | 0 | 0 | 0 | For |
| Gabelli | 16,200 | 0 | 0 | 0 | For |
| American Century | 14,376 | 0 | 0 | 0 | For |
| Northern Trust | 13,478 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,077 | 0 | 0 | 0 | For |
| Global X | 11,690 | 0 | 0 | 0 | For |
| Pacific Life | 9,102 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,061 | 0 | 0 | 0 | For |
| Voya | 8,363 | 0 | 0 | 0 | For |
| GuideStone | 8,221 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,063 | 0 | 0 | 0 | For |
| ProShares | 4,748 | 0 | 0 | 0 | For |
| Victory Capital | 3,606 | 0 | 0 | 0 | For |
| DWS | 3,380 | 0 | 0 | 0 | For |
| Calvert | 2,087 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,566 | 0 | 0 | 0 | For |
| State Street | 1,552 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Meeting held November 7, 2024.
Combines 4 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: To elect four non-Series A Preferred Director, as described in the Proxy Statement, for a term expiring at the 2025 annual meeting stockholders and until their successors are duly elected and qualified: Katrina L. Houde
LIFECORE BIOMEDICAL INC.’s own tally for this item (“Elect Director: Katrina Houde”): 20,973,514 for, 2,827,981 against, per its Form 8-K filed November 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,471,658 for, 557,411 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,293,361 | 0 | 0 | 0 | For |
| BlackRock | 0 | 229,840 | 0 | 0 | Against |
| Fidelity | 146,786 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 60,505 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 55,700 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 42,480 | 0 | 0 | Against |
| Equitable | 15,200 | 11,970 | 0 | 0 | Mixed |
| TIAA | 0 | 26,237 | 0 | 0 | Against |
| Lincoln Financial | 0 | 17,000 | 0 | 0 | Against |
| Gabelli | 16,200 | 0 | 0 | 0 | For |
| American Century | 0 | 14,376 | 0 | 0 | Against |
| Northern Trust | 0 | 13,478 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 12,077 | 0 | 0 | Against |
| Global X | 0 | 11,690 | 0 | 0 | Against |
| Pacific Life | 0 | 9,102 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 9,061 | 0 | 0 | Against |
| Voya | 0 | 8,363 | 0 | 0 | Against |
| GuideStone | 0 | 8,221 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 6,063 | 0 | 0 | Against |
| ProShares | 0 | 4,748 | 0 | 0 | Against |
| Victory Capital | 0 | 3,606 | 0 | 0 | Against |
| DWS | 0 | 3,380 | 0 | 0 | Against |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| T. Rowe Price | 0 | 1,566 | 0 | 0 | Against |
| State Street | 0 | 1,552 | 0 | 0 | Against |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Meeting held November 7, 2024.
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: To elect four non-Series A Preferred Director, as described in the Proxy Statement, for a term expiring at the 2025 annual meeting stockholders and until their successors are duly elected and qualified: Matthew Korenberg
LIFECORE BIOMEDICAL INC.’s own tally for this item (“Elect Director: Matthew Korenberg”): 23,645,673 for, 191,321 against, per its Form 8-K filed November 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 2,029,069 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,293,361 | 0 | 0 | 0 | For |
| BlackRock | 229,840 | 0 | 0 | 0 | For |
| Fidelity | 146,786 | 0 | 0 | 0 | For |
| Charles Schwab | 60,505 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 55,700 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 42,480 | 0 | 0 | 0 | For |
| Equitable | 27,170 | 0 | 0 | 0 | For |
| TIAA | 26,237 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,000 | 0 | 0 | 0 | For |
| Gabelli | 16,200 | 0 | 0 | 0 | For |
| American Century | 14,376 | 0 | 0 | 0 | For |
| Northern Trust | 13,478 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,077 | 0 | 0 | 0 | For |
| Global X | 11,690 | 0 | 0 | 0 | For |
| Pacific Life | 9,102 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,061 | 0 | 0 | 0 | For |
| Voya | 8,363 | 0 | 0 | 0 | For |
| GuideStone | 8,221 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,063 | 0 | 0 | 0 | For |
| ProShares | 4,748 | 0 | 0 | 0 | For |
| Victory Capital | 3,606 | 0 | 0 | 0 | For |
| DWS | 3,380 | 0 | 0 | 0 | For |
| Calvert | 2,087 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,566 | 0 | 0 | 0 | For |
| State Street | 1,552 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Meeting held November 7, 2024.
Combines 4 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: To elect four non-Series A Preferred Director, as described in the Proxy Statement, for a term expiring at the 2025 annual meeting stockholders and until their successors are duly elected and qualified: Nelson Obus
LIFECORE BIOMEDICAL INC.’s own tally for this item (“Elect Director: Nelson Obus”): 21,721,070 for, 2,115,224 against, per its Form 8-K filed November 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,632,008 for, 397,061 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,293,361 | 0 | 0 | 0 | For |
| BlackRock | 0 | 229,840 | 0 | 0 | Against |
| Fidelity | 146,786 | 0 | 0 | 0 | For |
| Charles Schwab | 60,505 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 55,700 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 42,480 | 0 | 0 | Against |
| Equitable | 19,580 | 7,590 | 0 | 0 | Mixed |
| TIAA | 0 | 26,237 | 0 | 0 | Against |
| Lincoln Financial | 17,000 | 0 | 0 | 0 | For |
| Gabelli | 16,200 | 0 | 0 | 0 | For |
| American Century | 14,376 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 13,478 | 0 | 0 | Against |
| AIG/SunAmerica | 12,077 | 0 | 0 | 0 | For |
| Global X | 11,690 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 9,102 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 9,061 | 0 | 0 | Against |
| Voya | 8,363 | 0 | 0 | 0 | For |
| GuideStone | 8,221 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,063 | 0 | 0 | 0 | For |
| ProShares | 4,748 | 0 | 0 | 0 | For |
| Victory Capital | 3,606 | 0 | 0 | 0 | For |
| DWS | 3,380 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| T. Rowe Price | 1,566 | 0 | 0 | 0 | For |
| State Street | 1,552 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Meeting held August 15, 2024.
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect three non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Joshua E. Schechter
LIFECORE BIOMEDICAL INC.’s own tally for this item (“Elect Director: Joshua E. Schechter”): 20,771,379 for, 919,721 against, per its Form 8-K filed August 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 1,358,723 for, 67,421 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,174,091 | 0 | 0 | 0 | For |
| Fidelity | 63,632 | 0 | 0 | 0 | For |
| BlackRock | 0 | 46,777 | 0 | 0 | Against |
| Equitable | 43,205 | 988 | 0 | 0 | For |
| American Century | 43,407 | 0 | 0 | 0 | For |
| Gabelli | 19,300 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 16,116 | 0 | 0 | Against |
| Charles Schwab | 10,427 | 0 | 0 | 0 | For |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 3,540 | 0 | 0 | Against |
| John Hancock | 729 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
Meeting held August 15, 2024.
Combines 2 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: To elect three non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Paul Josephs
LIFECORE BIOMEDICAL INC.’s own tally for this item (“Elect Director: Paul Josephs”): 21,583,747 for, 82,517 against, per its Form 8-K filed August 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 1,426,144 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,174,091 | 0 | 0 | 0 | For |
| Fidelity | 63,632 | 0 | 0 | 0 | For |
| BlackRock | 46,777 | 0 | 0 | 0 | For |
| Equitable | 44,193 | 0 | 0 | 0 | For |
| American Century | 43,407 | 0 | 0 | 0 | For |
| Gabelli | 19,300 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 16,116 | 0 | 0 | 0 | For |
| Charles Schwab | 10,427 | 0 | 0 | 0 | For |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Northern Trust | 3,540 | 0 | 0 | 0 | For |
| John Hancock | 729 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
Meeting held August 15, 2024.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect three non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Raymond Diradoorian
LIFECORE BIOMEDICAL INC.’s own tally for this item (“Elect Director: Raymond Diradoorian”): 21,156,969 for, 534,131 against, per its Form 8-K filed August 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 1,399,601 for, 26,543 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,174,091 | 0 | 0 | 0 | For |
| Fidelity | 63,632 | 0 | 0 | 0 | For |
| BlackRock | 46,777 | 0 | 0 | 0 | For |
| Equitable | 44,193 | 0 | 0 | 0 | For |
| American Century | 43,407 | 0 | 0 | 0 | For |
| Gabelli | 19,300 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 16,116 | 0 | 0 | Against |
| Charles Schwab | 0 | 10,427 | 0 | 0 | Against |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Northern Trust | 3,540 | 0 | 0 | 0 | For |
| John Hancock | 729 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
Meeting held August 15, 2024.
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To approve the amendment of Article VI of the Amended and Restated Certificate of Incorporation of Lifecore Biomedical, Inc., as amended (the "Charter"), to provide for the phased in declassification of the Board of Directors.
The 11 asset managers below reported 1,426,033 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,174,091 | 0 | 0 | 0 | For |
| Fidelity | 63,632 | 0 | 0 | 0 | For |
| BlackRock | 46,777 | 0 | 0 | 0 | For |
| Equitable | 44,193 | 0 | 0 | 0 | For |
| American Century | 43,407 | 0 | 0 | 0 | For |
| Gabelli | 19,300 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 16,116 | 0 | 0 | 0 | For |
| Charles Schwab | 10,427 | 0 | 0 | 0 | For |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Northern Trust | 3,540 | 0 | 0 | 0 | For |
| John Hancock | 729 | 0 | 0 | 0 | For |
Meeting held April 10, 2025.
Combines 2 wordings of this item as funds reported it.
99.2% of fund votes cast · no official result
Description as filed by funds: For purposes of complying with Nasdaq Listing Rule 5635(d), to approve the issuance of shares of our common stock ("Common Stock") underlying shares of Series A Preferred Stock, par value $0.001 per share, of the Company (the "Series A Preferred Stock") issued by the Company pursuant to the terms of that certain Securities Purchase Agreement, dated January 9, 2023, by and among the Company and the investors named therein, in an amount in excess of 19.99% of the number of shares of Common Stock outstanding immediately prior to the issuance of such Series A Preferred Stock (the "Issuance Proposal").
The 26 asset managers below reported 2,306,423 for, 19,718 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,503,843 | 0 | 0 | 0 | For |
| Fidelity | 521,469 | 0 | 0 | 0 | For |
| Equitable | 90,430 | 0 | 0 | 0 | For |
| Charles Schwab | 74,427 | 0 | 0 | 0 | For |
| WisdomTree | 26,569 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 17,000 | 0 | 0 | Against |
| Northern Trust | 13,478 | 0 | 0 | 0 | For |
| Global X | 12,829 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 12,564 | 0 | 0 | 0 | For |
| Pacific Life | 11,349 | 0 | 0 | 0 | For |
| Voya | 7,440 | 0 | 0 | 0 | For |
| ProShares | 5,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,696 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,980 | 0 | 0 | 0 | For |
| Victory Capital | 3,837 | 0 | 0 | 0 | For |
| Nationwide | 3,751 | 0 | 0 | 0 | For |
| DWS | 3,517 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,122 | 0 | 0 | 0 | For |
| Calvert | 2,087 | 0 | 0 | 0 | For |
| Brighthouse | 1,822 | 0 | 0 | 0 | For |
| State Street | 0 | 1,062 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 0 | 900 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 0 | 756 | 0 | 0 | Against |
| TIAA | 289 | 0 | 0 | 0 | For |
| Guggenheim | 203 | 0 | 0 | 0 | For |
Showing the 25 largest of 26 asset managers. All 26 are in the interactive database (link above).
Meeting held August 15, 2024.
Combines 2 wordings of this item as funds reported it.
91% Approved · of votes cast
Description as filed by funds: TO APPROVE THE AMENDMENT OF ARTICLE VI OF THE CHARTER TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK.
LIFECORE BIOMEDICAL INC.’s own tally for this item (“7. Amendment to the Certificate of Incorporation to increase the number of authorized shares of Common Stock”): 26,647,770 for, 2,676,222 against — passed, per its Form 8-K filed August 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The amendment to the Certificate of Incorporation to increase the number of authorized shares of Common Stock was approved, with votes as follows: Holders of Common Stock and Series A Preferred Stock voting as a single class:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 1,426,144 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,174,091 | 0 | 0 | 0 | For |
| Fidelity | 63,632 | 0 | 0 | 0 | For |
| BlackRock | 46,777 | 0 | 0 | 0 | For |
| Equitable | 44,193 | 0 | 0 | 0 | For |
| American Century | 43,407 | 0 | 0 | 0 | For |
| Gabelli | 19,300 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 16,116 | 0 | 0 | 0 | For |
| Charles Schwab | 10,427 | 0 | 0 | 0 | For |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Northern Trust | 3,540 | 0 | 0 | 0 | For |
| John Hancock | 729 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
Meeting held April 10, 2025.
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: FOR PURPOSES OF COMPLYING WITH NASDAQ LISTING RULE 5635(D), TO APPROVE THE ISSUANCE OF SHARES OF OUR COMMON STOCK UNDERLYING SHARES OF SERIES A PREFERRED STOCK, PAR VALUE $0.001 PER SHARE, OF THE COMPANY ISSUED BY THE COMPANY PURSUANT TO THE TERMS OF THAT CERTAIN SECURITIES PURCHASE AGREEMENT, DATED JANUARY 9, 2023, BY AND AMONG THE COMPANY AND THE INVESTORS NAMED THEREIN, IN AN AMOUNT IN EXCESS OF 19.99% OF THE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING IMMEDIATELY PRIOR TO THE ISSUANCE OF SUCH SERIES A PREFERRED STOCK.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 625,781 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 36,236 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 29,300 | 0 | 0 | 0 | For |
| Gabelli | 13,500 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 11,817 | 0 | 0 | 0 | For |
| John Hancock | 9,255 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 70 | 0 | 0 | 0 | For |
Fund voting reports, all 7 managers: 725,959 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Legion Partners Asset Management, LLC | 4,431,823 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 4,431,823 for.
Meeting held April 10, 2025.
99.3% of fund votes cast · no official result
Description as filed by funds: TO APPROVE AN ADJOURNMENT OF THE SPECIAL MEETING, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF THE ISSUANCE PROPOSAL.
The 33 asset managers below reported 3,030,260 for, 21,840 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,503,843 | 0 | 0 | 0 | For |
| BlackRock | 625,781 | 0 | 0 | 0 | For |
| Fidelity | 521,469 | 0 | 0 | 0 | For |
| Equitable | 90,430 | 0 | 0 | 0 | For |
| Charles Schwab | 74,427 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 36,236 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 29,300 | 0 | 0 | 0 | For |
| WisdomTree | 26,569 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 17,000 | 0 | 0 | Against |
| Gabelli | 13,500 | 0 | 0 | 0 | For |
| Northern Trust | 13,478 | 0 | 0 | 0 | For |
| Global X | 12,829 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 12,564 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 11,817 | 0 | 0 | 0 | For |
| Pacific Life | 11,349 | 0 | 0 | 0 | For |
| John Hancock | 9,255 | 0 | 0 | 0 | For |
| Voya | 7,440 | 0 | 0 | 0 | For |
| ProShares | 5,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,696 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,980 | 0 | 0 | 0 | For |
| Victory Capital | 3,837 | 0 | 0 | 0 | For |
| Nationwide | 3,751 | 0 | 0 | 0 | For |
| DWS | 3,517 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 2,122 | 0 | 0 | Against |
| Calvert | 2,087 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Meeting held August 15, 2024.
Combines 2 wordings of this item as funds reported it.
98% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO APPROVE AN AMENDMENT TO THE COMPANY'S 2019 STOCK INCENTIVE PLAN, INCLUDING AN INCREASE IN THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE THEREUNDER BY 300,000 SHARES OF COMMON STOCK.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,174,091 | 0 | 0 | 0 | For |
| Fidelity | 63,632 | 0 | 0 | 0 | For |
| BlackRock | 46,777 | 0 | 0 | 0 | For |
| Equitable | 988 | 43,205 | 0 | 0 | Against |
| American Century | 0 | 43,407 | 0 | 0 | Against |
| Gabelli | 0 | 19,300 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 16,116 | 0 | 0 | 0 | For |
| Charles Schwab | 10,427 | 0 | 0 | 0 | For |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Northern Trust | 3,540 | 0 | 0 | 0 | For |
| John Hancock | 729 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
Fund voting reports, all 12 managers: 1,320,232 for, 105,912 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Legion Partners Asset Management, LLC | 2,940,340 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 2,940,340 for.
Meeting held November 7, 2024.
Combines 8 wordings of this item as funds reported it.
99.3% Approved · of votes cast
Description as filed by funds: To approve a non-binding advisory proposal on the compensation of the Company's named executive officers, as described in the Proxy Statement.
LIFECORE BIOMEDICAL INC.’s own tally for this item (“3. The compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes”): 23,645,284 for, 163,003 against — passed, per its Form 8-K filed November 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes as follows:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,293,361 | 0 | 0 | 0 | For |
| BlackRock | 229,840 | 0 | 0 | 0 | For |
| Fidelity | 146,786 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 55,700 | 0 | 0 | 0 | For |
| Charles Schwab | 50,078 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 42,480 | 0 | 0 | 0 | For |
| Equitable | 27,170 | 0 | 0 | 0 | For |
| TIAA | 26,237 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,000 | 0 | 0 | 0 | For |
| Gabelli | 16,200 | 0 | 0 | 0 | For |
| American Century | 14,376 | 0 | 0 | 0 | For |
| Northern Trust | 13,478 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,077 | 0 | 0 | 0 | For |
| Global X | 11,690 | 0 | 0 | 0 | For |
| Pacific Life | 9,102 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,061 | 0 | 0 | 0 | For |
| Voya | 8,363 | 0 | 0 | 0 | For |
| GuideStone | 8,221 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,063 | 0 | 0 | 0 | For |
| ProShares | 4,748 | 0 | 0 | 0 | For |
| Victory Capital | 3,606 | 0 | 0 | 0 | For |
| DWS | 3,380 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| T. Rowe Price | 1,566 | 0 | 0 | 0 | For |
| State Street | 1,552 | 0 | 0 | 0 | For |
Fund voting reports, all 31 managers: 2,015,715 for, 2,198 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Legion Partners Asset Management, LLC | 4,403,754 | 0 | 0 | 0 | For |
| Greenhaven Road Investment Management, L.P. | 3,616,146 | 0 | 0 | 0 | For |
| WYNNEFIELD CAPITAL INC | 3,483,137 | 0 | 0 | 0 | For |
| 22NW, LP | 1,771,697 | 0 | 0 | 0 | For |
| 325 CAPITAL LLC | 1,369,785 | 0 | 0 | 0 | For |
| BlackRock | 506,700 | 0 | 0 | 0 | For |
| State Street | 298,528 | 0 | 0 | 0 | For |
| DCF Advisers, LLC | 0 | 288,478 | 0 | 0 | Against |
| Rangeley Capital, LLC | 211,799 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 154,451 | 0 | 0 | 0 | For |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 151,700 | 0 | 0 | 0 | For |
| Northern Trust | 122,943 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 92,106 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 66,261 | 0 | 0 | 0 | For |
| Charles Schwab | 60,505 | 0 | 0 | 0 | For |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 57,896 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,700 | 0 | 0 | 0 | For |
| Nuveen | 26,237 | 0 | 0 | 0 | For |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 25,354 | 0 | 0 | 0 | For |
| Vanguard | 23,957 | 0 | 0 | 0 | For |
| Gabelli | 21,200 | 0 | 0 | 0 | For |
| American Century | 14,376 | 0 | 0 | 0 | For |
| Rhumbline | 9,970 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 9,925 | 0 | 0 | Against |
| Boston Partners | 9,155 | 0 | 0 | 0 | For |
Institutional-manager reports, all 67 managers: 16,612,916 for, 311,530 against. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held August 15, 2024.
Combines 4 wordings of this item as funds reported it.
99.5% Approved · of votes cast
Description as filed by funds: TO APPROVE A NON-BINDING ADVISORY PROPOSAL ON THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN THE PROXY STATEMENT.
LIFECORE BIOMEDICAL INC.’s own tally for this item (“4. The compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes”): 21,573,480 for, 112,769 against — passed, per its Form 8-K filed August 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes as follows:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,174,091 | 0 | 0 | 0 | For |
| Fidelity | 63,632 | 0 | 0 | 0 | For |
| BlackRock | 46,777 | 0 | 0 | 0 | For |
| Equitable | 44,193 | 0 | 0 | 0 | For |
| American Century | 43,407 | 0 | 0 | 0 | For |
| Gabelli | 19,300 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 16,116 | 0 | 0 | 0 | For |
| Charles Schwab | 10,427 | 0 | 0 | 0 | For |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Northern Trust | 3,540 | 0 | 0 | 0 | For |
| John Hancock | 729 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
Fund voting reports, all 12 managers: 1,426,144 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 4,165,822 | 0 | 0 | 0 | For |
| Legion Partners Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| 325 CAPITAL LLC | 1,340,598 | 0 | 0 | 0 | For |
| BlackRock | 255,059 | 0 | 0 | 0 | For |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 151,700 | 0 | 0 | 0 | For |
| State Street | 120,796 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 105,386 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 101,421 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 69,868 | 0 | 0 | 0 | For |
| Gabelli | 48,205 | 0 | 0 | 0 | For |
| Diversified Trust Co | 46,062 | 0 | 0 | 0 | For |
| American Century | 43,407 | 0 | 0 | 0 | For |
| Northern Trust | 32,815 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 22,674 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 16,116 | 0 | 0 | 0 | For |
| Citadel | 13,958 | 0 | 0 | 0 | For |
| Vanguard | 13,671 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 11,112 | 0 | 0 | 0 | For |
| Charles Schwab | 10,427 | 0 | 0 | 0 | For |
| Sterling Capital Management LLC | 10,000 | 0 | 0 | 0 | For |
| Crestwood Advisors Group, LLC | 6,890 | 0 | 0 | 0 | For |
| HM PAYSON & CO | 5,000 | 0 | 0 | 0 | For |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Nierenberg Investment Management Company, Inc. | 3,355 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,964 | 0 | 0 | 0 | For |
Institutional-manager reports, all 48 managers: 6,610,039 for, 28 against, 2,940,340 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held August 15, 2024.
Combines 2 wordings of this item as funds reported it.
— Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO APPROVE A NON-BINDING ADVISORY PROPOSAL ON THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE THE COMPANY'S NAMED EXECUTIVE OFFICER COMPENSATION.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Gabelli | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 12 managers: 1,426,144 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| 325 CAPITAL LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Gabelli | 0 | 0 | 0 | 0 | -- |
| Diversified Trust Co | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Laurion Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Sterling Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| Crestwood Advisors Group, LLC | 0 | 0 | 0 | 0 | -- |
| HM PAYSON & CO | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Nierenberg Investment Management Company, Inc. | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Ethic Inc. | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 45 managers: 2,444,203 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held November 7, 2024.
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF BDO USA, P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING MAY 25, 2025.
LIFECORE BIOMEDICAL INC.’s own tally for this item (“2. The appointment of BDO USA, P.C”): 31,279,291 for, 29,609 against — passed, per its Form 8-K filed November 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending May 25, 2025, with votes as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 2,029,069 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,293,361 | 0 | 0 | 0 | For |
| BlackRock | 229,840 | 0 | 0 | 0 | For |
| Fidelity | 146,786 | 0 | 0 | 0 | For |
| Charles Schwab | 60,505 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 55,700 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 42,480 | 0 | 0 | 0 | For |
| Equitable | 27,170 | 0 | 0 | 0 | For |
| TIAA | 26,237 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,000 | 0 | 0 | 0 | For |
| Gabelli | 16,200 | 0 | 0 | 0 | For |
| American Century | 14,376 | 0 | 0 | 0 | For |
| Northern Trust | 13,478 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,077 | 0 | 0 | 0 | For |
| Global X | 11,690 | 0 | 0 | 0 | For |
| Pacific Life | 9,102 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,061 | 0 | 0 | 0 | For |
| Voya | 8,363 | 0 | 0 | 0 | For |
| GuideStone | 8,221 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,063 | 0 | 0 | 0 | For |
| ProShares | 4,748 | 0 | 0 | 0 | For |
| Victory Capital | 3,606 | 0 | 0 | 0 | For |
| DWS | 3,380 | 0 | 0 | 0 | For |
| Calvert | 2,087 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,566 | 0 | 0 | 0 | For |
| State Street | 1,552 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Meeting held August 15, 2024.
99.5% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF BDO USA, P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING MAY 26, 2024.
LIFECORE BIOMEDICAL INC.’s own tally for this item (“3. The appointment of BDO USA, P.C”): 29,200,561 for, 143,197 against — passed, per its Form 8-K filed August 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending May 26, 2024, with votes as follows:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 1,426,144 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,174,091 | 0 | 0 | 0 | For |
| Fidelity | 63,632 | 0 | 0 | 0 | For |
| BlackRock | 46,777 | 0 | 0 | 0 | For |
| Equitable | 44,193 | 0 | 0 | 0 | For |
| American Century | 43,407 | 0 | 0 | 0 | For |
| Gabelli | 19,300 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 16,116 | 0 | 0 | 0 | For |
| Charles Schwab | 10,427 | 0 | 0 | 0 | For |
| Victory Capital | 3,821 | 0 | 0 | 0 | For |
| Northern Trust | 3,540 | 0 | 0 | 0 | For |
| John Hancock | 729 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 30,898,255 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.87% |
| 2 | BlackRock | 2.03% |
| 3 | Fidelity | 1.69% |
| 4 | Equitable | 0.29% |
| 5 | Charles Schwab | 0.24% |
| 6 | QUANTITATIVE MASTER SERIES LLC | 0.12% |
| 7 | RBC FUNDS TRUST | 0.09% |
| 8 | WisdomTree | 0.09% |
| 9 | Lincoln Financial | 0.06% |
| 10 | Gabelli | 0.04% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Legion Partners Asset Management, LLC | 14.25% |
| 2 | Greenhaven Road Investment Management, L.P. | 11.70% |
| 3 | WYNNEFIELD CAPITAL INC | 11.27% |
| 4 | 22NW, LP | 5.73% |
| 5 | 325 CAPITAL LLC | 4.43% |
| 6 | BlackRock | 1.64% |
| 7 | State Street | 0.97% |
| 8 | DCF Advisers, LLC | 0.93% |
| 9 | Rangeley Capital, LLC | 0.69% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0.50% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Christopher S. Kiper | 6,762,432 | — | Proxy statement (DEF 14A), proxy filed September 18, 2025 |
| Legion Partners Asset Management, LLC | 6,762,432 | — | Proxy statement (DEF 14A), proxy filed September 18, 2025 |
| Nelson Obus | 5,420,561 | — | Proxy statement (DEF 14A), proxy filed September 18, 2025 |
| Wynnefield Capital, Inc. | 5,420,561 | — | Proxy statement (DEF 14A), proxy filed September 18, 2025 |
| Capital | 3,082,710 | — | Proxy statement (DEF 14A), proxy filed September 18, 2025 |
| 22NW, LP | 3,024,758 | — | Proxy statement (DEF 14A), proxy filed September 18, 2025 |
| 22NW Fund, LP | 2,975,398 | — | Schedule 13D, filed May 29, 2025 |
| Greenhaven Road Investment Management, L.P. | 2,366,956 | — | Schedule 13G, filed February 14, 2025 |
| LW Capital Management | 1,899,992 | — | Proxy statement (DEF 14A), proxy filed September 18, 2025 |
| David Capital Partners, LLC | 1,803,000 | — | Schedule 13G, filed February 5, 2025 |
Percentages above are of 30,898,255 shares outstanding, as reported by LIFECORE BIOMEDICAL INC. on its Form 10-Q dated September 27, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At LIFECORE BIOMEDICAL INC.'s 3 shareholder meetings in the 2024-2025 proxy season (held August 15, 2024, November 7, 2024 and April 10, 2025), 105 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,069 separate fund positions. Their filings are grouped here into 18 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held November 7, 2024 — To approve a non-binding advisory proposal on the compensation of the Company's named executive… — LIFECORE BIOMEDICAL INC.'s filing reports the proposal as approved, with 99.3% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: LIFECORE BIOMEDICAL INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on November 8, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LIFECORE BIOMEDICAL INC.’s 10-Q dated September 27, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
LIFECORE BIOMEDICAL INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “LIFECORE BIOMEDICAL (LFCR) 2024-2025 Annual & Special Meetings”, https://proxyvotesnow.com/company/lifecore-biomedical-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.